Sequent Scientific zooms on completing acquisition of 40% stake in Provet

03 Nov 2020 Evaluate

Sequent Scientific is currently trading at Rs. 144.40, up by 6.45 points or 4.68% from its previous closing of Rs. 137.95 on the BSE.

The scrip opened at Rs. 135.50 and has touched a high and low of Rs. 144.55 and Rs. 135.50 respectively. So far 19020 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 168.80 on 08-Oct-2020 and a 52 week low of Rs. 52.00 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 151.95 and Rs. 135.50 respectively. The current market cap of the company is Rs. 3498.31 crore.

The promoters holding in the company stood at 54.51%, while Institutions and Non-Institutions held 13.12% and 32.37% respectively.

Sequent Scientific has completed acquisition of 40% stake in Provet through Alivira Animal Health, Ireland,Wholly Owned Subsidiary of the Company. On completion of the said transaction, Provet has become a Wholly Owned Subsidiary of the Company.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×